Kristina Warton

2.1k total citations
33 papers, 1.6k citations indexed

About

Kristina Warton is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kristina Warton has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Kristina Warton's work include Cancer Genomics and Diagnostics (17 papers), Epigenetics and DNA Methylation (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Kristina Warton is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Epigenetics and DNA Methylation (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Kristina Warton collaborates with scholars based in Australia, Italy and United States. Kristina Warton's co-authors include Goli Samimi, Stella M. Valenzuela, Samuel N. Breit, Terence J. Campbell, Caroline E. Ford, Neville F. Hacker, Michele Mazzanti, Raffaella Tonini, Kate Mahon and Min Qiu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Kristina Warton

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Warton Australia 15 1.1k 480 266 164 148 33 1.6k
Punit Saraon Canada 19 805 0.7× 267 0.6× 236 0.9× 240 1.5× 177 1.2× 25 1.5k
Alyssa E. Johnson United States 17 1.0k 0.9× 501 1.0× 344 1.3× 92 0.6× 99 0.7× 44 1.5k
Andrew Pierce United Kingdom 23 1.3k 1.1× 270 0.6× 423 1.6× 120 0.7× 75 0.5× 69 2.2k
Cem Elbi United States 23 1.4k 1.3× 219 0.5× 462 1.7× 323 2.0× 65 0.4× 38 2.2k
Yusuke Nakamura Japan 24 1.2k 1.1× 308 0.6× 457 1.7× 156 1.0× 57 0.4× 38 1.8k
Luciane R. Cavalli United States 26 1.3k 1.2× 864 1.8× 436 1.6× 223 1.4× 49 0.3× 94 2.1k
Antonella Manca Italy 25 1.4k 1.3× 466 1.0× 668 2.5× 156 1.0× 35 0.2× 67 2.2k
Holger Hess‐Stumpp Germany 18 973 0.9× 430 0.9× 307 1.2× 98 0.6× 180 1.2× 34 1.5k
Wei‐Hsiung Yang United States 19 694 0.6× 348 0.7× 237 0.9× 211 1.3× 102 0.7× 39 1.3k
Hanny Odijk Netherlands 21 2.3k 2.1× 576 1.2× 442 1.7× 90 0.5× 72 0.5× 28 2.8k

Countries citing papers authored by Kristina Warton

Since Specialization
Citations

This map shows the geographic impact of Kristina Warton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Warton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Warton more than expected).

Fields of papers citing papers by Kristina Warton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Warton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Warton. The network helps show where Kristina Warton may publish in the future.

Co-authorship network of co-authors of Kristina Warton

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Warton. A scholar is included among the top collaborators of Kristina Warton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Warton. Kristina Warton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Yeh Chen, et al.. (2024). Use of cell-free DNA from ascites to identify variants and tumour evolution in a cohort of patients with advanced ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). 5547–5547.
2.
Lee, Yeh Chen, et al.. (2024). Cell‐free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer. Molecular Oncology. 18(11). 2668–2683. 3 indexed citations
3.
Ford, Caroline E., et al.. (2024). Circulating cell-free DNA is elevated in postmenopausal compared with pre- and perimenopausal women. Menopause The Journal of The North American Menopause Society. 31(3). 171–175.
4.
5.
Hossain, Khondker R., Jonathan Bermeo, Kristina Warton, & Stella M. Valenzuela. (2022). New Approaches and Biomarker Candidates for the Early Detection of Ovarian Cancer. Frontiers in Bioengineering and Biotechnology. 10. 819183–819183. 8 indexed citations
6.
Henry, Claire, et al.. (2022). Circulating cell-free DNA undergoes significant decline in yield after prolonged storage time in both plasma and purified form. Clinical Chemistry and Laboratory Medicine (CCLM). 60(8). 1287–1298. 6 indexed citations
7.
Houshdaran, Sahar, et al.. (2021). Comparison of total and endometrial circulating cell-free DNA in women with and without endometriosis. Reproductive BioMedicine Online. 44(3). 495–503. 6 indexed citations
8.
Liu, Dongli, Catherine David, Pamela Provan, et al.. (2021). Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer. Gynecologic Oncology. 162(3). 720–727. 28 indexed citations
9.
Ford, Caroline E., et al.. (2020). The untapped potential of ascites in ovarian cancer research and treatment. British Journal of Cancer. 123(1). 9–16. 160 indexed citations
10.
Warton, Kristina, et al.. (2018). Comparison of 4 commercial kits for the extraction of circulating DNA from plasma. Cancer Genetics. 228-229. 143–150. 50 indexed citations
11.
Warton, Kristina, Kate Mahon, & Goli Samimi. (2016). Methylated circulating tumor DNA in blood: power in cancer prognosis and response. Endocrine Related Cancer. 23(3). R157–R171. 135 indexed citations
12.
Warton, Kristina & Goli Samimi. (2015). Methylation of cell-free circulating DNA in the diagnosis of cancer. Frontiers in Molecular Biosciences. 2. 13–13. 151 indexed citations
13.
Warton, Kristina, Nicola J. Armstrong, Warren Kaplan, et al.. (2014). Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma. BMC Genomics. 15(1). 476–476. 59 indexed citations
14.
Montavon, Céline, Brian Gloss, Kristina Warton, et al.. (2011). Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. Gynecologic Oncology. 124(3). 582–588. 86 indexed citations
15.
16.
Bockel, David van, David A. Price, Tedi E. Asher, et al.. (2007). Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood. Journal of Immunological Methods. 326(1-2). 127–138. 6 indexed citations
17.
Warton, Kristina, et al.. (2006). An in vitro study of the effects of exposure to a GSM signal in two human cell lines: Monocytic U937 and neuroblastoma SK-N-SH. Cell Biology International. 30(10). 793–799. 58 indexed citations
18.
Warton, Kristina, et al.. (2004). A novel gene family induced by acute inflammation in endothelial cells. Gene. 342(1). 85–95. 62 indexed citations
19.
Warton, Kristina, Raffaella Tonini, W. Douglas Fairlie, et al.. (2002). Recombinant CLIC1 (NCC27) Assembles in Lipid Bilayers via a pH-dependent Two-state Process to Form Chloride Ion Channels with Identical Characteristics to Those Observed in Chinese Hamster Ovary Cells Expressing CLIC1. Journal of Biological Chemistry. 277(29). 26003–26011. 110 indexed citations
20.
Harrop, S.J., Matthew Z. DeMaere, W. Douglas Fairlie, et al.. (2001). Crystal Structure of a Soluble Form of the Intracellular Chloride Ion Channel CLIC1 (NCC27) at 1.4-Å Resolution. Journal of Biological Chemistry. 276(48). 44993–45000. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Punit Saraon Breakdown of academic impact, for papers by Alyssa E. Johnson Breakdown of academic impact, for papers by Andrew Pierce Breakdown of academic impact, for papers by Cem Elbi Breakdown of academic impact, for papers by Yusuke Nakamura Breakdown of academic impact, for papers by Luciane R. Cavalli Breakdown of academic impact, for papers by Antonella Manca Breakdown of academic impact, for papers by Holger Hess‐Stumpp Breakdown of academic impact, for papers by Wei‐Hsiung Yang Breakdown of academic impact, for papers by Hanny Odijk
Rankless by CCL
2026